| 6.14 -0.25 (-3.91%) | 11-02 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 10.08  |
1-year : | 11.92 |
| Resists | First : | 8.63 |
Second : | 10.21 |
| Pivot price | 7.2 |
|||
| Supports | First : | 6.09 |
Second : | 5.07 |
| MAs | MA(5) : | 7.04 |
MA(20) : | 7.49 |
| MA(100) : | 7.9  |
MA(250) : | 5.48 |
|
| MACD | MACD : | -0.5 |
Signal : | -0.4 |
| %K %D | K(14,3) : | 17.1 |
D(3) : | 33.8 |
| RSI | RSI(14): 35.7 |
|||
| 52-week | High : | 10.21 | Low : | 1.89 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ BFLY ] has closed above bottom band by 0.7%. Bollinger Bands are 21.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 7.18 - 7.23 | 7.23 - 7.27 |
| Low: | 6.21 - 6.25 | 6.25 - 6.28 |
| Close: | 6.33 - 6.4 | 6.4 - 6.45 |
Butterfly Network, Inc. functions as a digital health enterprise, specializing in the invention, production, and global commercialization of cutting-edge ultrasound imaging technologies for both domestic and international markets. The company's innovative product portfolio includes the portable Butterfly iQ, a versatile single-probe system capable of whole-body ultrasound imaging, and the Butterfly iQ+, a point-of-care ultrasound device engineered to connect effortlessly with smartphones, tablets, and existing hospital computer networks. Additionally, Butterfly Blueprint is offered as a comprehensive, system-wide ultrasound platform that seamlessly integrates its proprietary Compass software into a healthcare provider's clinical and administrative infrastructure. These ultrasound systems, encompassing probes, related accessories, and software subscriptions, are supplied to healthcare systems, individual physicians, and other medical professionals through a multi-channel distribution strategy that includes a direct sales force, a network of distributors, and an e-commerce platform. Beyond its hardware, Butterfly Network provides a suite of cloud-based software solutions for healthcare organizations. These offerings feature teleguidance services, interactive in-app educational modules, and structured training programs delivered via its Butterfly Academy software, all complemented by dedicated clinical support and services. Established in 2011, Butterfly Network, Inc. has its corporate headquarters situated in Guilford, Connecticut.
Sun, 01 Nov 2026
Butterfly Network, Inc. (BFLY) Stock Price, News, Quote & History - Yahoo! Finance Canada
Fri, 30 Oct 2026
Butterfly Network Q3 Earnings Call Highlights - TradingView
Thu, 29 Oct 2026
Butterfly Network Inc (BFLY) Q3 2026 Earnings Call Highlights: Record Margins, Surging Embedded ... - Yahoo Finance
Thu, 29 Oct 2026
Butterfly Network, Inc. Q3 2026 Earnings Call Summary - Yahoo Finance
Thu, 29 Oct 2026
Earnings call transcript: Butterfly Network tops Q3 2026 estimates, shares slip - Investing.com
Thu, 29 Oct 2026
(BFLY) Butterfly Network, Inc. Expects Q4 Revenue Range $31.0M - $34.0M - www.marketscreener.com
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 245 (M) |
| Shares Float | 220 (M) |
| Held by Insiders | 10.2 (%) |
| Held by Institutions | 61.9 (%) |
| Shares Short | 31,640 (K) |
| Shares Short P.Month | 34,060 (K) |
| EPS | -0.29 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.72 |
| Profit Margin | -66.8 % |
| Operating Margin | -30.9 % |
| Return on Assets (ttm) | -10.5 % |
| Return on Equity (ttm) | -35.5 % |
| Qtrly Rev. Growth | 39.5 % |
| Gross Profit (p.s.) | 0.31 |
| Sales Per Share | 0.45 |
| EBITDA (p.s.) | -0.2 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -24 (M) |
| Levered Free Cash Flow | 1 (M) |
| PE Ratio | -21.18 |
| PEG Ratio | 0 |
| Price to Book value | 8.52 |
| Price to Sales | 13.4 |
| Price to Cash Flow | -62.6 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|